Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Poly(adenosine diphosphate-ribose) polymerase-inhibitor response evaluation in recurrent epithelial ovarian cancer using circulating tumor DNA and functional homologous recombination-deficient testing
Merel Vegter; Lise M van Wijk; Claire J H Kramer; Hilde Jalving; Tjalling Bosse; Dik C van Gent; Sylvia Gelpke-Vermeulen; Corine M Beaufort; Marcel A T M van Vugt; Titia G Meijer; Heleen J van Beekhuizen; Maurice P H M Jansen; Maaike P G Vreeswijk; Ingrid A Boere; Judith R KroepShow moreShow less
Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Gynecological Oncology, Rotterdam, The Netherlands; Leiden University Medical Center, Department of Human Genetics, Leiden, The Netherlands; Leiden University Medical Center, Department of Pathology, Leiden, The Netherlands; University Medical Center Groningen, Department of Medical Oncology, Groningen, The Netherlands; Erasmus MC, Department of Molecular Genetics, Rotterdam, The Netherlands; Erasmus MC Cancer Institute, University Medical Center Rotterdam, Department of Medical Oncology, Rotterdam, The Netherlands; Leiden University Medical Center, Department of Medical Oncology, Leiden, The NetherlandsShow moreShow less
Patient characteristics and clinical indicators influencing oncologists’ perceptions of prognosis in ovarian cancer: a discrete choice experiment
Robert L. Coleman; Zulikhat Segunmaru; Elizabeth A. Szamreta; Kathryn Krupsky; Kathleen Beusterien; M. Janelle Cambron-Mellott; Michael F. Barry; Nicole Kashine; Emily Mulvihill; Daniel SimmonsShow moreShow less
US Oncology Network, Texas Oncology, Gynecologic Oncology, The Woodlands, TX, USA; Editorial Board Member, International Journal of Gynecological Cancer, USA; Oncology Outcomes Research, AstraZeneca, Gaithersburg, MD, USA; Outcome Research, Merck & Co, Inc, Rahway, NJ, USA; Real World Evidence, Oracle Life Sciences, Austin, TX, USAShow moreShow less
Not all artificial intelligence large language models are created equal: heterogeneous performance in therapeutic decision-making for recurrent epithelial ovarian cancer
Fulvio Borella; Stefano Fucina; Pietro Denti; Niccolò Gallio; Luca Bertero; Antonino Ditto; Isabelle Ray-Coquard; Nicolas Chopin; Domenico Ferraioli; Stefano CosmaShow moreShow less
Città della Salute e della Scienza, Sant’Anna Hospital, University of Turin, Division of Gynecology and Obstetrics 1U, Department of Surgical Sciences, Turin, Italy; National Cancer Institute, IRCCS CRO Aviano, Unit of Gynecologic Oncology Surgery, Aviano, Italy; Città della Salute e della Scienza, Sant’Anna Hospital, University of Turin, Gynecology and Obstetrics 2U, Department of Surgical Sciences, Turin, Italy; Città della Salute e della Scienza, University of Turin, Pathology Unit, Department of Medical Sciences, Turin, Italy; Centre Leon Berard and Claude Bernard University, Department of Adult Medical Oncology, Lyon, France; Centre Leon Berard and Claude Bernard University, Department of Surgical Oncology, Lyon, FranceShow moreShow less
Incidence and early prediction of post-operative pancreatic fistula after splenectomy in ovarian cancer cytoreduction within an enhanced recovery after surgery pathway: the ERASPLEEN study
Marco D’Indinosante; Nicolò Bizzarri; Alice Zampolini Faustini; Diana Giannarelli; Barbara Costantini; Angelica Naldini; Francesco Santullo; Claudio Lodoli; Marco Cintoni; Francesco Fanfani; Anna FagottiShow moreShow less
Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento Scienze della Salute della Donna e del Bambino, Unità Operativa Complessa di Ginecologia Oncologica, Roma, Italy; Università Cattolica del Sacro Cuore, Roma, Italy; Editorial Board Member, International Journal of Gynecological Cancer; FPO-IRCCS, Candiolo Cancer Institute, Ovarian Cancer Center, Candiolo, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Facility of Epidemiology and Biostatistics, G-STEP Generator, Roma, Italy; University of Health Sciences, Saint Camillus International, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Peritoneum and Retroperitoneum Surgical Unit, Rome, Italy; Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Scienze Mediche e Chirurgiche, Unità Operativa Complessa di Nutrizione Clinica, Rome, Italy; Università Cattolica del Sacro Cuore, Centro di Ricerca e Formazione in Nutrizione Umana, Rome, ItalyShow moreShow less
Implementation of a gynecologic oncology ultrasound training program to support cervical cancer staging at Queen Elizabeth Central Hospital in Malawi
George Kassim Chilinda; Samuel James Meja; Roman Kocián; Mariateresa Mirandola; Yacinta Pindulani; Sylvie Goossens; Victor Mwapasa; Inne H.M. Borel Rinkes; Denis Querleu; Pierre-Francois Dupre; Marcus J. RijkenShow moreShow less
Queen Elizabeth Central Hospital, Gynaecological Oncology Unit, Department of Obstetrics & Gynaecology, Blantyre, Malawi; Kamuzu University of Health Sciences, School of Public Health, Department of Health Systems and Policy, Blantyre, Malawi; Kamuzu University of Health Sciences, School of Medicine, Department of Obstetrics and Gynaecology, Blantyre, Malawi; Charles University and General University Hospital in Prague, First Faculty of Medicine, Gynaecologic Oncology Centre, Department of Gynaecology, Obstetrics and Neonatology, Prague, Czech Republic; IRCCS, Fondazione Policlinico Universitario Agostino Gemelli, Dipartimento Scienze della Salute della Donna del Bambino e di Sanità Pubblica, Rome, Italy; Università Cattolica del Sacro Cuore, Dipartimento Universitario di Scienze della Vita e Sanità Pubblica, Roma, Italia; Netherlands Cancer Institute-Antoni van Leeuwenhoek, Centre of Gynaecologic Oncology, Department of Gynaecologic Oncology, Amsterdam, The Netherlands; Utrecht University, University Medical Centre Utrecht, Julius Centre for Health Science and Primary Care, Julius Global Health, Utrecht, The Netherlands; Utrecht University, University Medical Centre, Department of Oncology, Utrecht, The Netherlands; Université de Brest, Institut de Cancérologie et Hématologie, Service de Gynécologie-Obstétrique et Médecine de la Reproduction, Brest, France; Médecins Sans Frontières -Operation Centre Paris-Malawi mission, Blantyre Cervical Cancer project, Blantyre, Malawi; Médecins Sans Frontières – Operational Centre Paris, Paris, FranceShow moreShow less
Cervical cancer screening among transgender and gender diverse individuals: a systematic review and meta-analysis
Amelia Srajer; John M. Hutchinson; Amy Metcalfe; Darren R. Brenner; Kristin A. Black; Fiona Mattatall; Ioana Nicolau; Paul E. RonksleyShow moreShow less
University of Calgary, Cumming School of Medicine, Department of Community Health Sciences, Calgary, AB, Canada; University of Calgary, Cumming School of Medicine, Department of Obstetrics and Gynecology, Calgary, AB, Canada; University of Calgary, Cumming School of Medicine, Department of Oncology, Calgary, AB, Canada; University of Calgary, Cumming School of Medicine, Department of Medicine, Calgary, AB, Canada; Cancer Care Alberta, Department of Cancer Epidemiology and Prevention Research, Calgary, AB, CanadaShow moreShow less
FAQ
How long does INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER take to review a manuscript?
As of 2026-11-13, CrushSCI has 14 complete review records for INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. The fastest paper went from submission to acceptance in 52 days (Cervical cancer screening among transgender and gender diverse individuals: a systematic review and meta-analysis, received 2026-05-06, accepted 2026-06-27); the slowest took 172 days. The average is 99.2 days and the median is 95.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
